Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Stresses Consolidation in Five-Year Plan for Drug Distribution

publication date: May 11, 2011
As expected, consolidation is the theme of the 12th Five-year Plan (2011-15) for China’s drug distribution sector. In the plan, the Ministry of Commerce encouraged more M&A to continue the rollup of pharma distribution companies. The goal is to have, by the end of 2015, three national pharmaceutical distributors, each with annual revenues of at least 100 billion RMB ($15.4 billion). Underneath the top layer, the MoC wants to see the formation of 20 regional distributors with sales of more than 10 billion RMB ($1.5 billion). More details....

Share this with colleagues:  


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital